WHICH THROMBOLYTIC AGENT SHOULD ONE CHOOSE

被引：18

作者：

TOPOL, EJ ^{[1
]}

机构：

[1] CLEVELAND CLIN FDN, CTR THROMBOSIS & ARTERIAL BIOL, CLEVELAND, OH 44195 USA

来源：

PROGRESS IN CARDIOVASCULAR DISEASES | 1991年 / 34卷 / 03期

关键词：

D O I：

10.1016/0033-0620(91)90011-A

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：165 / 178

页数：14

共 57 条

[1] LONG-TERM (2-YEAR) BENEFICIAL-EFFECTS OF BETA-ADRENERGIC-BLOCKADE WITH BUCINDOLOL IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY [J].

ANDERSON, JL ;

GILBERT, EM ;

OCONNELL, JB ;

RENLUND, D ;

YANOWITZ, F ;

MURRAY, M ;

ROSKELLEY, M ;

MEALEY, P ;

VOLKMAN, K ;

DEITCHMAN, D ;

BRISTOW, M .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 17 (06) :1373-1381

[2] MULTICENTER PATENCY TRIAL OF INTRAVENOUS ANISTREPLASE COMPARED WITH STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION [J].

ANDERSON, JL ;

SORENSEN, SG ;

MORENO, FL ;

HACKWORTHY, RA ;

BROWNE, KF ;

DALE, HT ;

LEYA, F ;

DANGOISSE, V ;

ECKERSON, HW ;

MARDER, VJ .

CIRCULATION, 1991, 83 (01) :126-140

[3]

[Anonymous], 1988, LANCET, V2, P349

[4]

[Anonymous], 1986, LANCET, V1, P397

[5] EFFECT OF HEPARIN ON CORONARY ARTERIAL PATENCY AFTER THROMBOLYSIS WITH TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION [J].

BLEICH, SD ;

NICHOLS, TC ;

SCHUMACHER, RR ;

COOKE, DH ;

TATE, DA ;

TEICHMAN, SL .

AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (20) :1412-1417

[6]

BONNET JL, 1989, CIRCULATION S2, V80, P343

[7] LEFT-VENTRICULAR EJECTION FRACTION MAY NOT BE USEFUL AS AN END-POINT OF THROMBOLYTIC THERAPY COMPARATIVE TRIALS [J].

CALIFF, RM ;

HARRELSONWOODLIEF, L ;

TOPOL, EJ .

CIRCULATION, 1990, 82 (05) :1847-1853

[8] EVALUATION OF COMBINATION THROMBOLYTIC THERAPY AND TIMING OF CARDIAC-CATHETERIZATION IN ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THROMBOLYSIS AND ANGIOPLASTY IN MYOCARDIAL-INFARCTION PHASE-5 RANDOMIZED TRIAL [J].

CALIFF, RM ;

TOPOL, EJ ;

STACK, RS ;

ELLIS, SG ;

GEORGE, BS ;

KEREIAKES, DJ ;

SAMAHA, JK ;

WORLEY, SJ ;

ANDERSON, JL ;

HARRELSONWOODLIEF, L ;

WALL, TC ;

PHILLIPS, HR ;

ABBOTTSMITH, CW ;

CANDELA, RJ ;

FLANAGAN, WH ;

SASAHARA, AA ;

MANTELL, SJ ;

LEE, KL .

CIRCULATION, 1991, 83 (05) :1543-1556

[9]

CARNEY R, 1990, CIRCULATION, V82, P538

[10] THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE [J].

CHESEBRO, JH ;

KNATTERUD, G ;

ROBERTS, R ;

BORER, J ;

COHEN, LS ;

DALEN, J ;

DODGE, HT ;

FRANCIS, CK ;

HILLIS, D ;

LUDBROOK, P ;

MARKIS, JE ;

MUELLER, H ;

PASSAMANI, ER ;

POWERS, ER ;

RAO, AK ;

ROBERTSON, T ;

ROSS, A ;

RYAN, TJ ;

SOBEL, BE ;

WILLERSON, J ;

WILLIAMS, DO ;

ZARET, BL ;

BRAUNWALD, E .

CIRCULATION, 1987, 76 (01) :142-154

← 1 2 3 4 5 6 →